Scientific Expertise and Innovation
We know that healthcare providers rely on diagnostic laboratories for much more than just quality testing and accurate results. That’s why, in this rapidly changing healthcare environment, we attract the most outstanding scientists to keep our testing services on the cutting edge, and bring healthcare providers clinically relevant, financially responsible testing options. Our laboratory is backed by a large medical staff comprised of MDs, PhDs, genetic counselors, cytologists, board-certified pathologists, technologists, laboratory scientists, and other professional clinical personnel..
For almost 40 years our clients have counted on BioReference® to stay at the forefront of the industry. From routine tests to highly specialized esoteric assays, we cover all diagnostic testing needs with 99% of our tests performed in-house for convenient ordering, cumulative reporting and better patient care and management.
The Future of Medicine
The COVID-19 pandemic has significantly changed how healthcare providers and patients view healthcare, and telemedicine has grown at an unprecedented rate. These changes will continue to transform healthcare and diagnostics now and in the future. As a physician-founded and physician-led laboratory, BioReference® has always challenged the industry with a patient-centric approach. Now, as the healthcare industry moves into the next era, BioReference® is prepared to meet the evolving needs of healthcare providers and consumers with solutions that are proven, agile, collaborative, patient-centric and digitally enabled. Our laboratory makes strategic investments in emerging laboratory technology to ensure scientific excellence. BioReference® is pleased to bring healthcare provider innovative testing solutions and services, including:
Use the 4Kscore® to accurately identify a man’s risk of developing aggressive prostate cancer.
Use the Heart Health Lipoprotein Particle Profile to accurately determine and diagnose cardiovascular risk.
Use OnkoMatch to identify over 100 mutations across 14 key cancer genes from one tissue sample.
Use the STORMPATH® remote pathology solution to provide a complete, easy-to-use web-based interface for ordering, analyzing and reporting patient test results.
Use GenPap® to identify multiple pathogens from a single sample.
Use InheriGen® carrier screening to determine a patient’s risk of having a baby with an inherited genetic disorder.
Use the Hereditary Cancer Program to accurately and appropriately identify individuals at risk for a hereditary cancer syndrome.
Use the Multiplex test for differentiating COVID-19 patients from those with Influenza A or B (flu), the PCR test to detect the presence of SARS-CoV-2 and the antibody test to identify patients who have been successfully vaccinated or have been previously exposed to COVID-19 in the past.